Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
Identificadores
Identificadores
Data de publicación
2015Título da revista
AMERICAN JOURNAL OF HEMATOLOGY
Tipo de contido
Artigo